GKOS
Glaukos Corporation
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+26/100
Last price
161.59
▼ 2.42 (1.48%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
164.00
Prev close
164.01
Day high
164.00
Day low
160.58
Volume
664.41K
Market cap
$9.53B
P/E (TTM)
—
52W range
73.16 – 191.62
Day trading desk
Gap from prior close
+0.15%
Prior close 163.75
VWAP
161.84
-0.16% from price
Relative volume
1.35×
Normal
Session range
3.75%
160.30 – 166.31
Position in range
21%
Near session low
ATR (14D)
6.49
4.02% of price
Prior day high
168.08
PDH
Prior day low
163.01
PDL
Bid / ask spread
—
Quote not published
Session volume
1.07M
Avg 792.63K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+3.44%
+1.5%
1M
-9.06%
-10.2%
3M
+8.87%
+4.3%
6M
+40.55%
+22.4%
YTD
+45.26%
+31.0%
1Y
+94.12%
+77.7%
3Y
+115.24%
+33.0%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on GKOS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-211
Net selling
Buy transactions
24
173.79K shares
Sell transactions
17
174.00K shares
Net transactions
+41
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
2.11M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 25, 26 | NAVRATIL TOMAS Officer |
SELL | 1.61K | $249.16K | Direct |
| Aug 28, 26 | NAVRATIL TOMAS Officer |
SELL | 13.74K | $2.48M | Direct |
| Aug 19, 26 | KLIMAN GILBERT H. Director |
SELL | 2.50K | $475.00K | Direct |
| Aug 19, 26 | KLIMAN GILBERT H. Director |
CONVERSION | 2.50K | $64.42K | Direct |
| Aug 11, 26 | GILLIAM JOSEPH E. President |
SELL | 60.00K | $10.78M | Direct |
| Aug 11, 26 | GILLIAM JOSEPH E. President |
CONVERSION | 60.00K | $3.18M | Direct |
| Aug 7, 26 | THURMAN ALEX R. Chief Financial Officer |
SELL | 20.00K | $3.60M | Direct |
| Aug 7, 26 | THURMAN ALEX R. Chief Financial Officer |
CONVERSION | 20.00K | $676.20K | Direct |
| Jul 31, 26 | WEN LEANA Director |
SELL | 525 | $88.01K | Direct |
| Jul 16, 26 | THURMAN ALEX R. Chief Financial Officer |
SELL | 10.00K | $1.60M | Direct |
| Jul 16, 26 | THURMAN ALEX R. Chief Financial Officer |
CONVERSION | 10.00K | $386.80K | Direct |
| Jul 9, 26 | THURMAN ALEX R. Chief Financial Officer |
SELL | 10.00K | $1.55M | Direct |
| Jul 9, 26 | THURMAN ALEX R. Chief Financial Officer |
CONVERSION | 10.00K | $386.80K | Direct |
| Jul 6, 26 | THURMAN ALEX R. Chief Financial Officer |
SELL | 10.00K | $1.50M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BURNS THOMAS WILLIAM |
Chief Executive Officer | 1.77M | Stock Gift |
FOLEY MARK J |
Director | 60.27K | Stock Award(Grant) |
GILLIAM JOSEPH E. |
President | 72.59K | Sale |
HOFFMEISTER DAVID F |
Director | 87.72K | Stock Award(Grant) |
KLIMAN GILBERT H. |
Director | 37.41K | Sale |
NAVRATIL TOMAS |
Officer | 70.82K | Sale |
STAPLEY MARC A |
Director | 39.33K | Stock Award(Grant) |
THURMAN ALEX R. |
Chief Financial Officer | 43.91K | Sale |
TORRES DENICE |
Director | 24.21K | Stock Award(Grant) |
WEISNER AIMEE S |
Director | 52.19K | Stock Award(Grant) |
Fundamentals
Market cap$9.53B
Enterprise value$9.35B
Revenue (TTM)$612.84M
Gross profit$484.88M
EBITDA$-37.02M
Net income$-188.05M
EPS (TTM)$-3.26
Free cash flow$15.46M
Total cash$286.23M
Total debt$107.60M
Book value / share$11.60
Shares outstanding58.98M
Float56.83M
Short % of float8.55%
Dividend yield0.00%
Beta (5Y)0.70
Valuation & profitability ratios
Trailing P/E—
Forward P/E308.64
PEG ratio—
Price / sales—
Price / book13.94
EV / revenue15.25
EV / EBITDA-252.48
Gross margin79.12%
Operating margin-8.49%
Profit margin-30.69%
Return on equity-25.98%
Return on assets-5.18%
Debt / equity15.77
Current ratio5.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $507.44M | $383.48M | $314.71M | $282.86M | +32.3% |
| Operating revenue | $507.44M | $383.48M | $314.71M | $282.86M | +32.3% |
| Cost of revenue | $224.68M | $94.03M | $75.58M | $68.98M | +139.0% |
| Gross profit | $282.76M | $289.45M | $239.14M | $213.88M | -2.3% |
| Research & development | $150.61M | $136.43M | $138.77M | $123.27M | +10.4% |
| Selling, general & admin | $331.75M | $261.17M | $224.07M | $192.93M | +27.0% |
| Total operating expense | $482.36M | $397.59M | $362.84M | $316.20M | +21.3% |
| Operating income | -$199.60M | -$108.14M | -$123.70M | -$102.31M | -84.6% |
| Net interest income | $6.08M | $1.06M | -$4.47M | -$11.35M | +470.8% |
| Pre-tax income | -$193.04M | -$145.60M | -$133.73M | -$98.43M | -32.6% |
| Tax provision | -$5.35M | $771.00K | $934.00K | $766.00K | -794.0% |
| Net income | -$187.69M | -$146.37M | -$134.66M | -$99.19M | -28.2% |
| Net income to common | -$187.69M | -$146.37M | -$134.66M | -$99.19M | -28.2% |
| Basic EPS | -3.28 | -2.77 | -2.78 | -2.09 | -18.4% |
| Diluted EPS | -3.28 | -2.77 | -2.78 | -2.09 | -18.4% |
| EBIT | -$188.41M | -$135.56M | -$120.09M | -$84.71M | -39.0% |
| EBITDA | -$146.06M | -$95.64M | -$82.12M | -$48.76M | -52.7% |
| Basic shares | 57.19M | 52.76M | 48.43M | 47.44M | +8.4% |
| Diluted shares | 57.19M | 52.76M | 48.43M | 47.44M | +8.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $90.81M | $169.63M | $93.47M | $119.53M | — | -46.5% |
| Cash & short-term investments | $278.76M | $318.92M | $295.43M | $352.69M | — | -12.6% |
| Accounts receivable | $108.61M | $60.74M | $39.85M | $36.07M | — | +78.8% |
| Inventory | $63.56M | $57.68M | $41.99M | $37.84M | — | +10.2% |
| Total current assets | $474.98M | $449.79M | $395.46M | $443.86M | — | +5.6% |
| Property, plant & equipment | $184.18M | $169.94M | $174.54M | $166.83M | — | +8.4% |
| Goodwill & intangibles | $208.63M | $329.58M | $349.09M | $374.00M | — | -36.7% |
| Total assets | $893.49M | $974.76M | $940.41M | $1.00B | — | -8.3% |
| Total current liabilities | $101.28M | $75.13M | $74.01M | $72.36M | — | +34.8% |
| Long-term debt | — | — | $282.77M | $281.40M | $280.03M | — |
| Total debt | $103.88M | $103.40M | $383.74M | $382.48M | — | +0.5% |
| Total liabilities | $237.33M | $207.82M | $478.65M | $472.38M | — | +14.2% |
| Retained earnings | -$933.13M | -$745.44M | -$599.07M | -$464.41M | — | -25.2% |
| Shareholder equity | $656.15M | $766.93M | $461.77M | $530.00M | — | -14.4% |
| Working capital | $373.71M | $374.67M | $321.45M | $371.50M | — | -0.3% |
| Net tangible assets | $447.53M | $437.35M | $112.68M | $156.00M | — | +2.3% |
| Shares issued | 57.54M | 56.47M | 49.15M | 47.78M | — | +1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$187.69M | -$146.37M | -$134.66M | -$99.19M | -28.2% |
| Depreciation & amortisation | $42.34M | $39.92M | $37.98M | $35.95M | +6.1% |
| Stock-based compensation | $63.22M | $50.21M | $43.53M | $38.56M | +25.9% |
| Change in working capital | -$48.02M | -$40.05M | -$10.49M | -$13.45M | -19.9% |
| Operating cash flow | -$14.79M | -$61.32M | -$57.76M | -$33.08M | +75.9% |
| Capital expenditure | -$24.27M | -$6.30M | -$20.25M | -$30.27M | -285.3% |
| Investing cash flow | -$77.61M | $47.83M | $14.10M | $44.78M | -262.3% |
| Financing cash flow | $11.89M | $91.54M | $15.04M | $6.25M | -87.0% |
| Free cash flow | -$39.06M | -$67.62M | -$78.01M | -$63.35M | +42.2% |
| End cash position | $94.65M | $174.36M | $99.32M | $126.60M | -45.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $185.61M | $150.57M | $143.12M | $133.54M | $124.12M | +23.3% |
| Operating revenue | $185.61M | $150.57M | $143.12M | $133.54M | $124.12M | +23.3% |
| Cost of revenue | $34.02M | $33.34M | $144.64M | $28.83M | $26.90M | +2.0% |
| Gross profit | $151.59M | $117.23M | -$1.52M | $104.71M | $97.22M | +29.3% |
| Research & development | $51.30M | $44.15M | $43.65M | $38.07M | $36.54M | +16.2% |
| Selling, general & admin | $116.06M | $92.94M | $94.70M | $83.00M | $83.38M | +24.9% |
| Total operating expense | $167.36M | $137.09M | $138.35M | $121.07M | $119.91M | +22.1% |
| Operating income | -$15.77M | -$19.86M | -$139.87M | -$16.36M | -$22.69M | +20.6% |
| Net interest income | $820.00K | $1.31M | $1.37M | $1.38M | $1.42M | -37.2% |
| Pre-tax income | -$17.72M | -$19.30M | -$139.82M | -$16.00M | -$19.41M | +8.2% |
| Tax provision | $656.00K | $484.00K | -$6.16M | $234.00K | $248.00K | +35.5% |
| Net income | -$18.38M | -$19.78M | -$133.66M | -$16.23M | -$19.66M | +7.1% |
| Net income to common | -$18.38M | -$19.78M | -$133.66M | -$16.23M | -$19.66M | +7.1% |
| Basic EPS | -0.31 | -0.34 | -2.32 | -0.28 | -0.34 | +8.8% |
| Diluted EPS | -0.31 | -0.34 | -2.32 | -0.28 | -0.34 | +8.8% |
| EBIT | -$16.26M | -$18.17M | -$138.67M | -$14.82M | -$18.26M | +10.5% |
| EBITDA | -$6.12M | -$5.29M | -$125.44M | -$4.63M | -$8.63M | -15.6% |
| Basic shares | 58.82M | 58.02M | 57.51M | 57.40M | 57.20M | +1.4% |
| Diluted shares | 58.82M | 58.02M | 57.51M | 57.40M | 57.20M | +1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $114.48M | $104.25M | $90.81M | $98.25M | $100.81M | +9.8% |
| Cash & short-term investments | $286.23M | $276.69M | $278.76M | $273.71M | $274.79M | +3.4% |
| Accounts receivable | $138.90M | $119.69M | $108.61M | $98.68M | $82.98M | +16.0% |
| Inventory | $59.31M | $62.38M | $63.56M | $63.86M | $64.62M | -4.9% |
| Total current assets | $515.78M | $485.75M | $474.98M | $454.77M | $436.06M | +6.2% |
| Property, plant & equipment | $181.58M | $182.26M | $184.18M | $182.49M | $184.41M | -0.4% |
| Goodwill & intangibles | $193.86M | $199.74M | $208.63M | $330.85M | $337.20M | -2.9% |
| Total assets | $920.52M | $893.33M | $893.49M | $999.38M | $986.96M | +3.0% |
| Total current liabilities | $102.33M | $89.42M | $101.28M | $87.52M | $79.14M | +14.4% |
| Total debt | $102.84M | $103.06M | $103.88M | $104.31M | $105.02M | -0.2% |
| Total liabilities | $238.03M | $222.40M | $237.33M | $229.84M | $221.85M | +7.0% |
| Retained earnings | -$971.29M | -$952.91M | -$933.13M | -$799.47M | -$783.24M | -1.9% |
| Shareholder equity | $682.49M | $670.93M | $656.15M | $769.54M | $765.11M | +1.7% |
| Working capital | $413.45M | $396.34M | $373.71M | $367.25M | $356.93M | +4.3% |
| Net tangible assets | $488.63M | $471.19M | $447.53M | $438.70M | $427.91M | +3.7% |
| Shares issued | 58.86M | 58.39M | 57.54M | 57.41M | 57.28M | +0.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$18.38M | -$19.78M | -$133.66M | -$16.23M | -$19.66M | +7.1% |
| Depreciation & amortisation | $10.14M | $12.88M | $13.23M | $10.19M | $9.62M | -21.3% |
| Stock-based compensation | $28.86M | $19.14M | $17.30M | $14.91M | $18.02M | +50.8% |
| Change in working capital | -$11.19M | -$23.83M | -$2.13M | -$15.66M | -$7.05M | +53.0% |
| Operating cash flow | $14.82M | -$12.53M | $6.84M | -$10.09M | $6.98M | +218.3% |
| Capital expenditure | -$2.74M | -$3.96M | -$19.52M | -$1.64M | -$1.18M | +30.8% |
| Investing cash flow | -$5.31M | $10.50M | -$15.89M | -$3.99M | -$20.78M | -150.5% |
| Financing cash flow | $991.00K | $15.77M | $2.43M | $5.26M | $2.25M | -93.7% |
| Free cash flow | $12.09M | -$16.48M | -$12.68M | -$11.72M | $5.80M | +173.3% |
| End cash position | $117.60M | $108.08M | $94.65M | $102.08M | $104.65M | +8.8% |
Options analytics
Put / call volume
2.20
Put-heavy session
Put / call open interest
1.80
Positioning, not flow
Max pain
160.00
-1.0% from spot
ATM implied vol
63.4%
Nearest strike to spot
Skew (10% OTM)
-1.2%
Calls bid over puts
Call volume
207
Contracts, this expiry
Put volume
456
Contracts, this expiry
Heaviest call OI
160.00
1.17K contracts
Heaviest put OI
140.00
1.27K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.21 | -0.14 | +33.5% |
| Mar 2026 | -0.28 | -0.18 | +35.9% |
| Dec 2025 | -0.20 | -0.28 | -43.2% |
| Sep 2025 | -0.26 | -0.16 | +38.9% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.09 | 13 | $167.91M | +25.7% |
| Next quarter | 0.11 | 13 | $186.98M | +30.6% |
| Current year | -0.29 | 13 | $691.01M | +36.2% |
| Next year | 0.52 | 13 | $850.24M | +23.0% |
Analyst targets & ownership
Mean target$198.69
High target$225.00
Low target$172.00
Implied upside22.96%
Analyst count13
ConsensusSTRONG BUY
Strong buy / Buy3 / 10
Hold1
Sell / Strong sell0 / 0
Held by insiders3.58%
Held by institutions105.07%
Institutions holding498
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
159.49
+1.32% from price
SMA 20
164.52
-0.31% from price
SMA 50
172.20
-4.76% from price
SMA 100
154.25
+4.76% from price
SMA 200
135.28
+21.23% from price
EMA 12
162.54
-0.58% from price
EMA 26
165.70
-2.48% from price
EMA 50
165.14
-2.15% from price
RSI (14)
47.3
Neutral
MACD (12,26,9)
-3.16
Hist 0.51
ATR (14)
6.49
3.96% of price
Realised vol 30D
34.5%
Annualised
Bollinger upper
180.16
20, 2σ
Bollinger lower
148.88
20, 2σ
50 / 200 cross
Golden
172.20 vs 135.28
Trend bias
Above 200
+21.23%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
-0.25
Less volatile than market
Correlation to SPY
-0.06
Largely independent
Realised vol 30D
34.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-28.4%
Peak to trough
Max drawdown 5Y
-53.7%
Peak to trough
ATR 14
6.49
3.96% of price
Beta (reported)
0.70
5Y monthly, from filing
Short interest
Shares short
4.17M
Prior 3.95M
Change vs prior
+5.4%
Shorts adding
% of float
8.55%
Normal
% of shares out
7.06%
Against total outstanding
Days to cover
6.4
Crowded exit
Float
56.83M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 22, 26 | Jefferies | MAINTAINED | Buy | Buy |
| Aug 20, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jul 30, 26 | UBS | MAINTAINED | Neutral | Neutral |
| Jul 30, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Jul 30, 26 | Jefferies | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Stifel | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Truist Securities | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Jul 30, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 30, 26 | BTIG | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-03
Periodic Financial Reports
10-Q · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-06-03
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-04
Periodic Financial Reports
10-Q · 2026-04-30
Corporate Changes & Voting Matters
8-K · 2026-04-29
Proxy Statements
DEF 14A · 2026-04-16
Headlines
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now
Zacks · 12d ago
Glaukos Partners with NBA Champion Stephen Curry to Launch "Could it be KC?" Campaign to Raise Awareness of Keratoconus
Business Wire · 14d ago
Glaukos (GKOS) Stock Looks Fully Priced Against Its Sales Growth Story
Simply Wall St. · 14d ago
Glaukos (GKOS), Why Is It Back In The Spotlight?
Simply Wall St. · 14d ago
When To Dump Stocks: These IBD 50 Components Hit Sell Signals
Investor's Business Daily · 18d ago
Idexx (IDXX) Down 7.8% Since Last Earnings Report: Can It Rebound?
Zacks · 33d ago
Glaukos Insider Sold Shares Worth $2,483,104, According to a Recent SEC Filing
MT Newswires · 35d ago
Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
Zacks · 35d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.